Optimising Molecular Radionuclide Therapy
Conditions:   Neuroendocrine Tumors;   Hyperthyroidism;   Thyroid Cancer;   Thyroid Carcinoma Interventions:   Diagnostic Test: Nuclear Medicine whole-body;   Diagnostic Test: SPECT/CT imaging.;   Diagnostic Test: PET/CT imaging.;   Device: Patient-led radiation monitor (SELFIE);   Diagnostic Test: LAB TEST Sponsors:   King's College London;   Guy's and St Thomas' NHS Foundation Trust Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - June 11, 2021 Category: Research Source Type: clinical trials